德菲洛克萨明通过抑制铁灭菌减轻了败血症引起的肝损伤
Haidan Zhang1, Hongyao Li1, Shixian Liu1
1Key Laboratory of Emergency Medicine, Emergency Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730000, Gansu Province, China.
Immunobiology
|October 9, 2025
概括
铁亡,一种细胞死亡的形式,显著导致败血症引起的肝损伤. 通过使用deferoxamine (DFO) 向ferroptosis显示出保护肝功能和改善败血症生存率的承诺.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 细胞死亡研究 细胞死亡研究
- 败血症病理生理学病理生理学
背景情况:
- 败血症经常导致肝损伤,这是早期死亡的关键因素.
- 铁亡与败血症器官功能障碍有关,但其在肝损伤中的具体作用尚不清楚.
- 这项研究研究了铁灭症在败血症相关的肝损伤中的作用和机制.
研究的目的:
- 为了阐明铁死在败血症引起的肝损伤中的作用.
- 探索这种情况中铁灭的潜在分子机制.
- 为了评估向毒症在败血症引起的肝损伤的治疗潜力.
主要方法:
- 已建立的老鼠败血症模型 (结和刺穿) 和体外肝细胞模型 (脂多糖刺激).
- 给药的德胺 (DFO),以评估其保护作用.
- 定量化的铁灭生物标志物 (Fe2+,PTGS2,ACSL4,MDA,GSH,GPX4),评估了脂质过氧化,并评估了线粒体功能.
主要成果:
- 在败血性大鼠中,DFO治疗减少了全身炎症,改善了生存率,并减轻了肝损伤.
- 在体外,DFO增强了肝细胞活力,并减少了铁和脂质过氧化的标志物.
- DFO减轻了线粒体损伤和改善了线粒体功能,同时增加了抗氧化能力 (GSH,GPX4).
结论:
- 铁致死症在败血症引起的肝损伤的发病过程中发挥着关键作用.
- 使用DFO向肝细胞中的ferroptosis激活,为败血症诱导的肝损伤提供了潜在的治疗策略.
相关概念视频
Necrosis
6.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
212
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
212


